{"transactions":[{"id":3042246,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-09-01T20:05:32.000Z","date":"2020-08-31","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were granted on August 9, 2017. 32,715 of the total shares vested and became exercisable immediately upon grant. 25% of the remaining stock options vested and became exercisable on July 23, 2018. 75% of the remaining stock options shall vest in 36 successive, equal monthly installments with the first such installment vesting and becoming exercisable on August 23, 2018."}],"balance_after":97961,"derivative":{"exercise_price":6.88,"expiration_date":"2027-08-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-101370","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465920101370/a4.xml","form_type":"4"}},{"id":3042245,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-09-01T20:05:32.000Z","date":"2020-08-31","kind":"sale","acquired":false,"shares":25000,"price":30,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 31, 2020, Ms. Desikan exercised and sold 25,000 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":43602,"source":{"system":"sec-edgar","filing":"0001104659-20-101370","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465920101370/a4.xml","form_type":"4"}},{"id":3042244,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-09-01T20:05:32.000Z","date":"2020-08-31","kind":"exercise","acquired":true,"shares":25000,"price":6.88,"value":172000.0,"ownership":{"direct":true},"balance_after":68602,"source":{"system":"sec-edgar","filing":"0001104659-20-101370","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465920101370/a4.xml","form_type":"4"}},{"id":3058248,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-08-13T20:05:42.000Z","date":"2020-08-11","kind":"exercise","acquired":false,"shares":14534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were granted on August 9, 2017. 32,715 of the total shares vested and became exercisable immediately upon grant. 25% of the remaining stock options vested and became exercisable on July 23, 2018. 75% of the remaining stock options shall vest in 36 successive, equal monthly installments with the first such installment vesting and becoming exercisable on August 23, 2018."}],"balance_after":122961,"derivative":{"exercise_price":6.88,"expiration_date":"2027-08-08","underlying":"Common Stock","underlying_shares":14534},"source":{"system":"sec-edgar","filing":"0001104659-20-094656","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465920094656/a4.xml","form_type":"4"}},{"id":3058247,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-08-13T20:05:42.000Z","date":"2020-08-11","kind":"exercise","acquired":true,"shares":14534,"price":6.88,"value":99993.92,"ownership":{"direct":true},"balance_after":43602,"source":{"system":"sec-edgar","filing":"0001104659-20-094656","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465920094656/a4.xml","form_type":"4"}},{"id":3090637,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-07-02T20:05:46.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on June 30, 2022, provided that if the Reporting Person incurs a qualifying termination on or prior to June 30, 2022, the restricted stock units will vest in full immediately prior to such qualifying termination. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in full on June 30, 2022, provided that if the Reporting Person incurs a qualifying termination on or prior to June 30, 2022, the restricted stock units will vest in full immediately prior to such qualifying termination. The restricted stock units have no expiration date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-080535","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465920080535/a4.xml","form_type":"4"}},{"id":3261871,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-19T21:24:49.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 14, 2020 and the shares underlying this option vest in sixteen equal quarterly installments beginning on May 14, 2020."}],"balance_after":80000,"derivative":{"exercise_price":17.87,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-20-022830","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465920022830/a4.xml","form_type":"4"}},{"id":3328655,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-31T21:02:01.000Z","date":"2019-12-27","kind":"exercise","acquired":false,"shares":35181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options were granted on August 9, 2017. 32,715 of the total shares vested and became exercisable immediately upon grant. 25% of the remaining stock options vested and became exercisable on July 23, 2018. 75% of the remaining stock options shall vest in 36 successive, equal monthly installments with the first such installment vesting and becoming exercisable on August 23, 2018."}],"balance_after":137495,"derivative":{"exercise_price":6.88,"expiration_date":"2027-08-08","underlying":"Common Stock","underlying_shares":35181},"source":{"system":"sec-edgar","filing":"0001104659-19-077301","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465919077301/a4.xml","form_type":"4"}},{"id":3328654,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-12-31T21:02:01.000Z","date":"2019-12-27","kind":"sale","acquired":false,"shares":35181,"price":22.7899,"value":801771.4719,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 27, 2019, Ms. Desikan sold 35,181 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.41 to $23.06, inclusive; the price reported above reflects the weighted average sale price. Ms. Desikan hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29068,"source":{"system":"sec-edgar","filing":"0001104659-19-077301","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465919077301/a4.xml","form_type":"4"}},{"id":3328653,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-12-31T21:02:01.000Z","date":"2019-12-27","kind":"exercise","acquired":true,"shares":35181,"price":6.88,"value":242045.28,"ownership":{"direct":true},"balance_after":64249,"source":{"system":"sec-edgar","filing":"0001104659-19-077301","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465919077301/a4.xml","form_type":"4"}},{"id":3439694,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-08-13T20:04:47.000Z","date":"2019-08-12","kind":"exercise","acquired":false,"shares":14534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were granted on August 9, 2017. 32,715 of the total shares vested and became exercisable immediately upon grant. 25% of the remaining stock options vested and became exercisable on July 23, 2018. 75% of the remaining stock options shall vest in 36 successive, equal monthly installments with the first such installment vesting and becoming exercisable on August 23, 2018."}],"balance_after":172676,"derivative":{"exercise_price":6.88,"expiration_date":"2027-08-08","underlying":"Common Stock","underlying_shares":14534},"source":{"system":"sec-edgar","filing":"0001104659-19-045574","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465919045574/a4.xml","form_type":"4"}},{"id":3439693,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-08-13T20:04:47.000Z","date":"2019-08-12","kind":"exercise","acquired":true,"shares":14534,"price":6.88,"value":99993.92,"ownership":{"direct":true},"balance_after":29068,"source":{"system":"sec-edgar","filing":"0001104659-19-045574","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465919045574/a4.xml","form_type":"4"}},{"id":3653106,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-15T21:09:21.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 13, 2019 and the shares underlying this option vest in sixteen equal quarterly installments beginning on May 13, 2019."}],"balance_after":70000,"derivative":{"exercise_price":29.78,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001104659-19-009042","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465919009042/a4.xml","form_type":"4"}},{"id":3844412,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-08-14T20:01:39.000Z","date":"2018-08-10","kind":"exercise","acquired":false,"shares":14534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were granted on August 9, 2017. 32,715 of the total shares vested and became exercisable immediately upon grant. 25% of the remaining stock options vested and became exercisable on July 23, 2018. 75% of the remaining stock options shall vest in 36 successive, equal monthly installments with the first such installment vesting and becoming exercisable on August 23, 2018."}],"balance_after":187210,"derivative":{"exercise_price":6.88,"expiration_date":"2027-08-08","underlying":"Common Stock","underlying_shares":14534},"source":{"system":"sec-edgar","filing":"0001104659-18-051945","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465918051945/a4.xml","form_type":"4"}},{"id":3844411,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-08-14T20:01:39.000Z","date":"2018-08-10","kind":"exercise","acquired":true,"shares":14534,"price":6.88,"value":99993.92,"ownership":{"direct":true},"balance_after":14534,"source":{"system":"sec-edgar","filing":"0001104659-18-051945","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465918051945/a4.xml","form_type":"4"}},{"id":4051134,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":146853,"kind":"person","name":"Desikan Nithya","position":1,"cik":"0001714105","reported_name":"Desikan Nithya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-16T21:02:41.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":61000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 14, 2018 and the shares underlying this option vest in sixteen equal quarterly installments."}],"balance_after":61000,"derivative":{"exercise_price":25.79,"expiration_date":"2028-02-13","underlying":"Common Stock","underlying_shares":61000},"source":{"system":"sec-edgar","filing":"0001104659-18-010367","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649904/000110465918010367/a4.xml","form_type":"4"}}]}